Showing results 1 to 3 of 3
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
Journal:Journal of the National Cancer Institute
Chan, Anthony T.C.Leung, S. F.Ngan, Roger K.C.Teo, Peter M.L.Lau, W. H.Kwan, W. H.Hui, Edwin P.Yiu, H. Y.Yeo, WinnieCheung, F. Y.Yu, K. H.Chiu, K. W.Chan, D. T.Mok, Tony S.K.Yau, StephenYuen, K. T.Mo, Frankie K.F.Lai, Maria M.P.Ma, Brigette B.Y.Kam, Michael K.M.Leung, Thomas W.T.Johnson, Philip J.Choi, Peter H.K.Zee, Benny C.Y.
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma